Combined with recent reports regarding the correlation between high levels of peripheral PD-L1 and poor cancer prognosis, our results suggest that circulating PD-L1 can act as an additional tumor immune suppressive mechanism outside the tumor microenvironment for cancer progression. This evidence concerns the gene CD274 and neoplasm.